Navigation Links
Researchers complete the first epigenome in Europe
Date:5/30/2012

A study led by Manel Esteller, director of the Epigenetics and Cancer Biology Program at the Bellvitge Biomedical Research Institute (IDIBELL), professor of genetics at the University of Barcelona and ICREA researcher, has completed the first epigenome in Europe. The finding is published in the latest issue of the international scientific journal Epigenetics.

The genome of all cells in the human body is the same for all of them, regardless their aspect and functions. Therefore, genome cannot fully explain the activity of tissues and organs and their disorders in complex diseases like cancer. It takes a further explanation. Part of this explanation is provided by epigenetics, a field of biology that studies the heredity activity of DNA that does not involve changes in its sequence. That is, if genetics is the alphabet, epigenetics is the spelling that guides the activity of our cells.

Methylation

Epigenetics refers to chemical changes in our genetic material and proteins that regulate it. The best-known epigenetic mark is the methylation, the addition of a methyl chemical group (-CH3) in our DNA. The epigenome consists of all the epigenetic marks of a living being.

The authors of the study have completed the epigenomes for all brands of methylation of DNA from white blood cells of two girls: a healthy one and a patient suffering from a rare genetic disease called Immunodeficiency, Centromere instability and Facial anomalies syndrome (ICF). This disease is caused by a mutation in a gene that causes the addition of a methyl chemical group in its DNA.

The analysis performed by the researchers reveals that the patient has an epigenomic defect that causes fragility of chromosomes, which thus can easily be broken. In addition, the study shows that the patient has a wrong epigenetic control of many genes related to the response against infection, which causes a severe immune deficiency.

The study coord
'/>"/>

Contact: Jordi Morato
comunicacio@idibell.cat
IDIBELL-Bellvitge Biomedical Research Institute
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. UC Santa Barbara researchers develop synthetic platelets
2. Researchers say tart cherries have the highest anti-inflammatory content of any food
3. CSHL researchers solve structure of human protein critical for silencing genes
4. Researchers identify genetic markers to predict male fertility
5. University of Hawaii Cancer Center researchers create new anti-cancer drug
6. UCLA researchers develop way to strengthen proteins with polymers
7. Tufts Medical Center researchers finds marker in premies saliva predicts readiness to feed by mouth
8. Researchers aim to assemble the tree of life for all 2 million named species
9. Dartmouth researchers are learning how exercise affects the brain
10. Nottingham researchers lead worlds largest study into pre-eclampsia
11. Begin early: Researchers say water with meals may encourage wiser choices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... presented at Digestive Disease Week (DDW) explores new ... lifestyle. , Individuals suffering from Crohn,s disease ... and poor quality of life. These symptoms can ... randomized, double blind, placebo-controlled study found for the ... significant relief of these symptoms. , "Our ...
(Date:5/17/2013)... Atlanta residents of all ages will celebrate the ... impact on our daily lives during the inaugural ... engineers and educators from local museums, corporations, K-12 ... than 40 different events for children and adults ... http://atlantasciencefestival.org . , The annual Atlanta ...
(Date:5/17/2013)... The Federation of American Societies for Experimental Biology ... Institutes of Health (NIH) funding trends highlighting the devastating ... critical research. The FASEB analysis follows a May 15th ... MD, PhD, who testified that the $1.6 billion cut ... is "having a substantial impact on the scientific community." ...
Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3First Atlanta Science Festival set for 2014 2
... A University of Leicester archaeologist has discovered a ... Staffordshire - believed to be the earliest archaeological evidence ... As reported in Post-Medieval Archaeology (volume 44/1) ... significance of the find is in the insights it ...
... your wedge may not help much, but mixing in longer ... studies have shown that variable practice improves the brain,s memory ... task. Cognitive neuroscientists at USC and UCLA describe the neural ... Nature Neuroscience . The researchers split 59 volunteers ...
... for regulating viruses that has worked its way into ... adult and fetal hemoglobin production, Medical College of Georgia ... to more targeted therapies for sickle cell patients whose ... throughout the body. Fetal hemoglobin, on the other ...
Cached Biology News:Archaeology find sheds new light on family pets 2Why (smart) practice makes perfect 2Modulator of fetal hemoglobin switch may target sickle cell disease 2Modulator of fetal hemoglobin switch may target sickle cell disease 3
(Date:5/20/2013)... , May 20, 2013 Cempra, ... on developing differentiated antibiotics to meet critical medical ... announced that it presented data at the American ... Philadelphia demonstrating the antibacterial and ... Cempra,s prior Phase 2 clinical trial in outpatients ...
(Date:5/20/2013)... 20, 2013 Recognizing exciting and ... members to its 2013 Class of Young Professors. ... will provide this outstanding international group with more ... basic science to meet global challenges.     , The ... promising young and untenured research faculty working in ...
(Date:5/19/2013)... Switzerland’s MS Tûranor PlanetSolar , the ... record for a transatlantic crossing by a solar electric ... 25, 2013, the solar powered boat sailed 2,867miles (5,310 ... of 5.3 knots before reaching Marigot, St. Martin, in ... first-of-its-kind catamaran completed this year’s passage across the Atlantic ...
(Date:5/17/2013)... rejection occurs when the transplant recipient,s immune system identifies ... It was previously thought that T cells, the immune ... molecules known as chemokines in order to migrate to ... Journal of Clinical Investigation , Fadi Lakkis and colleagues ... that chemokine stimulation of T cells is not required ...
Breaking Biology Technology:Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2DuPont Celebrates Scientific Innovation by Recognizing Young Professors 2DuPont Celebrates Scientific Innovation by Recognizing Young Professors 3MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 2MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 3MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 4MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 5MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 6
... LEUVEN, Belgium, August 27 ThromboGenics NV,(Euronext Brussels: THR), a ... for eye disease, vascular disease,and cancer, is today issuing a ... period ending 30 June, 2009. , ... which,are key to its aim of becoming a profitable, integrated ...
... Massachusetts and CHEADLE, England, August 27 ,Cardea Technology, ... and configure their software tools for Vertebral Fracture,Assessment, ... on bone,densitometers, to exchange information and create reports ... Optasia Medical Ltd. has developed SpineAnalyzer(TM), a ...
... , , ATLANTA, Aug. 27 ... million extension of its Series C financing which was originally completed in ... $5 million in Series C preferred stock received warrants for an additional ... have up to 30 days from the delivery of Phase III top-line ...
Cached Biology Technology:ThromboGenics NV Announces Business Update and Half Year Results 2009 2ThromboGenics NV Announces Business Update and Half Year Results 2009 3ThromboGenics NV Announces Business Update and Half Year Results 2009 4ThromboGenics NV Announces Business Update and Half Year Results 2009 5ThromboGenics NV Announces Business Update and Half Year Results 2009 6ThromboGenics NV Announces Business Update and Half Year Results 2009 7ThromboGenics NV Announces Business Update and Half Year Results 2009 8ThromboGenics NV Announces Business Update and Half Year Results 2009 9ThromboGenics NV Announces Business Update and Half Year Results 2009 10ThromboGenics NV Announces Business Update and Half Year Results 2009 11ThromboGenics NV Announces Business Update and Half Year Results 2009 12ThromboGenics NV Announces Business Update and Half Year Results 2009 13ThromboGenics NV Announces Business Update and Half Year Results 2009 14ThromboGenics NV Announces Business Update and Half Year Results 2009 15Cardea Technology Inc and Optasia Medical Ltd Announce Plans to Collaborate to Optimize Their Vertebral Fracture Assessment Tools 2Alimera Sciences Closes $5 Million in Extended Series C Financing 2
MOUSE ANTI HUMAN CYTOKERATIN 1-8...
GOAT ANTI HUMAN PSA (ISOFORM 1)...
... Immunogen: Synthetic peptide derived from the N-terminal ... ZO-1. Specificity: Specific for the N-terminus ... Reactivity: Human Dog Rat Mouse (positive controls: ... mouse liver heart blood vessel and brain ...
p-Raf-1 (Ser 338/Tyr 341)-R...
Biology Products: